A detailed history of Raleigh Capital Management Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Raleigh Capital Management Inc. holds 9,963 shares of JNJ stock, worth $1.52 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares
9,963
Previous 6,104 63.22%
Holding current value
$1.52 Million
Previous $892,000 80.94%
% of portfolio
0.63%
Previous 0.38%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$145.48 - $167.38 $561,407 - $645,919
3,859 Added 63.22%
9,963 $1.61 Million
Q2 2024

Jul 31, 2024

SELL
$144.38 - $157.78 $55,297 - $60,429
-383 Reduced 5.9%
6,104 $892,000
Q1 2024

May 13, 2024

BUY
$155.22 - $162.74 $155 - $162
1 Added 0.02%
6,487 $1.03 Million
Q4 2023

Feb 21, 2024

SELL
$145.6 - $158.88 $151,569 - $165,394
-1,041 Reduced 13.83%
6,486 $1.02 Million
Q3 2023

Dec 07, 2023

BUY
$155.75 - $174.48 $30,682 - $34,372
197 Added 2.69%
7,527 $1.17 Million
Q3 2023

Dec 06, 2023

BUY
$155.75 - $174.48 $217,427 - $243,574
1,396 Added 23.53%
7,330 $1.14 Million
Q2 2023

Jul 25, 2023

SELL
$154.35 - $166.11 $34,111 - $36,710
-221 Reduced 3.59%
5,934 $982,000
Q1 2023

May 22, 2023

BUY
$151.05 - $180.26 $70,842 - $84,541
469 Added 8.25%
6,155 $954,000
Q4 2022

Feb 07, 2023

BUY
$160.2 - $179.79 $19,704 - $22,114
123 Added 2.21%
5,686 $1 Million
Q3 2022

Nov 09, 2022

BUY
$161.33 - $179.52 $28,232 - $31,416
175 Added 3.25%
5,563 $909,000
Q2 2022

Aug 30, 2022

BUY
$168.19 - $186.01 $143,297 - $158,480
852 Added 18.78%
5,388 $956,000
Q1 2022

May 12, 2022

BUY
$158.14 - $179.59 $704,988 - $800,612
4,458 Added 5715.38%
4,536 $804,000
Q4 2021

Feb 16, 2022

BUY
$155.93 - $173.01 $12,162 - $13,494
78 New
78 $13,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $398B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Raleigh Capital Management Inc. Portfolio

Follow Raleigh Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raleigh Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raleigh Capital Management Inc. with notifications on news.